Realist process evaluation of occupational performance coaching: protocol.

Child & adolescent psychiatry Community child health Developmental neurology & neurodisability Patient Satisfaction Patient-Centered Care Rehabilitation medicine

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
06 Jun 2024
Historique:
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: epublish

Résumé

A cluster randomised controlled trial, the Meaning, Agency and Nurturing Autonomy (MANA) study, is underway comparing the effects of occupational performance coaching (OPC) and usual care on the social participation, health and well-being of children with neurodisability and their caregivers. This protocol presents the realist process evaluation which is occurring in parallel with the trial to allow testing and further refinement of OPC programme theory, as represented in its logic model. The aim of this realist evaluation is to examine what works, for whom, in the implementation of OPC with caregivers of children with neurodisability (in particular, Māori and Pasifika) in current service delivery contexts. Guided by OPC programme theory and realist evaluation processes, mixed-methods data collected from the MANA study OPC group will be analysed to elucidate when OPC works (outcomes), for whom, how (mechanisms) and under what circumstances (contexts). This will culminate in the synthesis of Intervention-Actor Context-Mechanism-Outcome configurations. Descriptive analyses will be reported for quantitative measures of treatment fidelity (OPC-Fidelity Measure), caregiver emotional response to OPC (Session Rating Scale) preintervention emotional state (Depression Stress and Anxiety Scale) and client outcomes (Canadian Occupational Performance Measure). Reflexive thematic analysis will be undertaken to analyse realist interviews with therapists who implemented OPC above and below fidelity thresholds and culturally focused interviews with clients of Māori or Pasifika ethnicity, informing understanding of the contexts influencing therapists' implementation of OPC with fidelity, and the mechanisms triggered within therapists or caregivers to elicit a response to the intervention. The MANA study trial outcomes will be reported separately. Ethical approval for this study was granted by the New Zealand Health and Disability Ethics Committee (20/STH/93). In all participating jurisdictions local area approval was obtained, involving a process of local Māori consultation. Results will be disseminated to all participants, and more broadly to clinicians and policy-makers through conference presentations and peer-reviewed journal publications, which will inform decision-making about resourcing and supporting effective delivery of OPC to optimise outcomes for children and caregivers. ACTRN12621000519853.

Identifiants

pubmed: 38844396
pii: bmjopen-2023-075727
doi: 10.1136/bmjopen-2023-075727
doi:

Types de publication

Journal Article Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

e075727

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: FG and the University of Otago provide commercial consultation services related to Occupational Performance Coaching.

Auteurs

Fiona Graham (F)

Department of Medicine, University of Otago, Wellington, New Zealand fi.graham@otago.ac.nz.

Jonathan Williman (J)

Public Health and General Practice, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand.

Laura Desha (L)

Department of Medicine, University of Otago, Wellington, New Zealand.

Deborah Snell (D)

University of Otago, Christchurch, New Zealand.

Bernadette Jones (B)

Department of Medicine, University of Otago, Wellington, New Zealand.

Tristram Ingham (T)

Department of Medicine, University of Otago, Wellington, New Zealand.

Anna Tiatia Fa'atoese Latu (ATF)

School of Pharmacy, University of Otago, Dunedin, New Zealand.

Annemarei Ranta (A)

Department of Medicine, University of Otago, Wellington, New Zealand.

Emma Walker (E)

Department of Medicine, University of Otago, Wellington, New Zealand.

Salote Makasini (S)

Department of Medicine, University of Otago, Wellington, New Zealand.

Jenny Ziviani (J)

The University of Queensland - Saint Lucia Campus, Saint Lucia, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH